BioForce Nanosciences Holdings, Inc.
BFNH
$1.50
$0.085.63%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 2.80% | 3.93% | 0.33% | 1.27% | 3.29% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -- | -- | -- | -- | -- |
Change in Net Operating Assets | 1.94% | -0.07% | 0.28% | 3.33% | -1.65% |
Cash from Operations | 31.63% | 27.84% | 4.49% | 25.29% | 12.10% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -19.55% | 18.69% | 15.91% | -16.84% | 17.96% |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -19.69% | 18.40% | 16.15% | -16.67% | 18.16% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 100.00% | 100.00% | 53.04% | 49.76% | 63.76% |